The importance of securing strong, long-standing investigator networks with leading research hospitals and clinics is critical to the continued growth of the clinical trial environment in countries such as Taiwan, says Evon Hui, Head of Business Operations, East Asia.

Over the past 15 years, George Clinical has cultivated an enviable network of MOUs that have cemented its position as a leading CRO in the region. One such MOU signed in 2015 with the Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital, has formalised a long-standing mutually beneficial relationship of cooperation and collaboration, focussed on increasing investigator networks and collaborative solutions that enhance study quality, study performance and shorten start-up timelines.

The Chang Gung Memorial Hospital offers the largest and most comprehensive health care services in Taiwan, comprised by a network of seven hospital branches located in Linkou, Taipei, Taoyuan, Keelung, Yunlin, Chiayi, and Kaohsiung.  Impressively, their hospital network:

  • Contains 10,050 beds
  • Receives an average of 8.2 million outpatient visits annually
  • Serves more than 2.4 million patients annually
  • Serves an average of 167,460 surgical patients every year.

It is estimated that a third of the Taiwanese population have sought treatment at Chang Gung.

“George Clinical has a number of years’ experience developing extensive investigator networks throughout Taiwan and East Asia,” Hui said following the MOU signing. “We have a long standing strategic focus on building the clinical trial infrastructure within Taiwan. Our work with the Chang Gung Medical Foundation since 2015 has provided our sponsors with significant access to populations and highly trained investigators throughout the country.”